Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept in Rheumatoid Arthritis (AUGUST I)
NCT00430495Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Dec 2006
- Primary completion
- Sep 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of atacicept in rheumatoid arthritis (RA), sponsored by EMD Serono. Started Dec 2006; status: completed.
02
Drugs
atacicept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00430495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430495.